ScoreWhy is NewAmsterdam Pharma Co. NV ?
1
Negative results in Dec 25
- NET SALES(HY) At USD 0.38 MM has Grown at -99.09%
- RAW MATERIAL COST(Y) Grown by 186.59% (YoY)
- PRE-TAX PROFIT(Q) Lowest at USD -59.59 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 22.26%, its profits have fallen by -11%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -2.61% over the previous quarter and currently hold 40.65% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is NewAmsterdam Pharma Co. NV for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
NewAmsterdam Pharma Co. NV
25.72%
0.83
56.99%
S&P 500
16.12%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
88.00%
EBIT Growth (5y)
-395.30%
EBIT to Interest (avg)
-83.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.04
Sales to Capital Employed (avg)
0.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.01
EV to EBIT
-12.35
EV to EBITDA
-12.36
EV to Capital Employed
60.60
EV to Sales
123.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-490.56%
ROE (Latest)
-27.07%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -107.8 MM
-17What is not working for the Company
NET SALES(HY)
At USD 0.38 MM has Grown at -99.09%
RAW MATERIAL COST(Y)
Grown by 186.59% (YoY
PRE-TAX PROFIT(Q)
Lowest at USD -59.59 MM
NET PROFIT(Q)
Lowest at USD -59.59 MM
Here's what is not working for NewAmsterdam Pharma Co. NV
Net Sales
At USD 0.38 MM has Grown at -99.09%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Pre-Tax Profit
Lowest at USD -59.59 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
Fallen at -27.84%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -59.59 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
Fallen at -27.84%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 186.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
